Body mass index and exon 19 mutation as factors predicting the therapeutic efficacy of gefitinib in patients with epidermal growth factor receptor mutation‐positive non‐small cell...

por Sun, Hongyan, Sun, Xiaoteng, Zhai, Xiaoyu, Guo, Jingfeng, Liu, Yutao, Ying, Jianming, Wang, Ziping
Publicado 2015